818
Views
23
CrossRef citations to date
0
Altmetric
Review Article

Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review

ORCID Icon, , ORCID Icon & ORCID Icon
Pages 685-695 | Received 22 Feb 2019, Accepted 22 Aug 2019, Published online: 23 Sep 2019

References

  • Alfano, C. M., and J. Rowland. 2006. “Recovery Issues in Cancer Survivorship: A New Challenge for Supportive Care.” The Cancer Journal 12 (5): 432–443. https://journals.lww.com/journalppo/Abstract/2006/09000/Recovery_Issues_in_Cancer_Survivorship__A_New.12.aspx doi:10.1097/00130404-200609000-00012
  • Atcherson, S. R., C. M. Richburg, R. I. Zraick, and C. M. George. 2013. “Readability of Questionnaires Assessing Listening Difficulties Associated with (Central) Auditory Processing Disorders.” Language, Speech, and Hearing Services in Schools 44 (1): 48–60. doi:10.1044/0161-1461(2012/11-0055).
  • Bentzen, A. G., L. Balteskard, E. H. Wanderås, G. Frykholm, T. Wilsgaard, O. Dahl, M. G. Guren, et al. 2013. “Impaired Health-Related Quality of Life after Chemoradiotherapy for Anal Cancer: Late Effects in a National Cohort of 128 Survivors.” Acta Oncologica (Stockholm, Sweden) 52 (4): 736–744. doi:10.3109/0284186X.2013.770599.
  • Bezjak, A., C. W. Lee, K. Ding, M. Brundage, T. Winton, B. Graham, M. Whitehead, et al. 2008. “Quality of Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non – Small-Cell Lung Cancer: Results from a Randomized Trial, JBR.10.” Journal of Clinical Oncology 26 (31): 5052–5059. doi:10.1200/JCO.2007.12.6094.
  • Biddle, L., S. Paramasivan, S. Harris, R. Campbell, J. Brennan, and W. Hollingworth. 2016. “Patients’ and Clinicians’ Experiences of Holistic Needs Assessment Using a Cancer Distress Thermometer and Problem List: A Qualitative Study.” European Journal of Oncology Nursing 23: 59–65. doi:10.1016/j.ejon.2016.04.004.
  • Bisht, M., and S. S. Bist. 2011. “Ototoxicity: The Hidden Menace.” Indian Journal of Otolaryngology and Head & Neck Surgery 63 (3): 255–259. doi:10.1007/s12070-011-0151-8.
  • Bokemeyer, C., C. C. Berger, J. T. Hartmann, C. Kollmannsberger, H. J. Schmoll, M. A. Kuczyk, and L. Kanz. 1998. “Analysis of Risk Factors for Cisplatin-Induced Ototoxicity in Patients with Testicular Cancer.” British Journal of Cancer 77 (8): 1355–1362. http://www.ncbi.nlm.nih.gov/pubmed/9579846 doi:10.1038/bjc.1998.226.
  • Bokemeyer, C., C. C. Berger, M. A. Kuczyk, and H. J. Schmoll. 1996. “Evaluation of Long-Term Toxicity after Chemotherapy for Testicular Cancer.” Journal of Clinical Oncology 14 (11): 2923–2932. doi:10.1200/JCO.1996.14.11.2923.
  • Calhoun, E. A., C. L. Bennett, P. A. Peeples, J. R. Lurain, P. Y. Roland, J. M. Weinstein, and D. A. Fishman. 1998. “Perceptions of Cisplatin-Related Toxicity among Ovarian Cancer Patients and Gynecologic Oncologists.” Gynecologic Oncology 71: 369–375. doi:10.1006/gyno.1998.5189.
  • Campbell, K. C. M., and C. G. Le Prell. 2018. “Drug-Induced Ototoxicity: Diagnosis and Monitoring.” Drug Safety 41 (5): 451–464. doi:10.1007/s40264-017-0629-8.
  • Chang, K. W. 2011. “Clinically Accurate Assessment and Grading of Ototoxicity.” The Laryngoscope 121 (12): 2649–2657. doi:10.1002/lary.22376.
  • Chirtes, F., and S. Albu. 2016. “Prevention and Restoration of Hearing Loss Associated with the Use of Cisplatin.” BioMed Research International 2014: 9. doi:10.1155/2014/925485.
  • Crundwell, G., P. Gomersall, and D. M. Baguley. 2016. “Ototoxicity (Cochleotoxicity) Classifications: A Review.” International Journal of Audiology 55 (2): 65–74. doi:10.3109/14992027.2015.1094188.
  • Deal, J. A., J. Betz, K. Yaffe, T. Harris, E. Purchase-Helzner, S. Satterfield, S. Pratt, et al. 2016. “Hearing Impairment and Incident Dementia and Cognitive Decline in Older Adults: The Health ABC Study.” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 72 (5): glw069. doi:10.1093/gerona/glw069.
  • Degeest, S., P. Corthals, I. Dhooge, and H. Keppler. 2016. “The Impact of Tinnitus Characteristics and Associated Variables on Tinnitus-Related Handicap.” The Journal of Laryngology & Otology 130 (01): 25–31. doi:10.1017/S0022215115002716.
  • Douglas, A., and R. J. Kelly-Campbell. 2018. “Readability of Patient-Reported Outcome Measures in Adult Audiologic Rehabilitation.” American Journal of Audiology 27 (2): 208–218. doi:10.1044/2018_AJA-17-0095.
  • Fellinger, J., D. Holzinger, J. Gerich, and D. Goldberg. 2007. “Mental Distress and Quality of Life in the Hard of Hearing.” Acta Psychiatrica Scandinavica 115 (3): 243–245. doi:10.1111/j.1600-0447.2006.00976.x.
  • Fosså, B. S. D., R. De Wit, J. T. Roberts, P. M. Wilkinson, P. H. M. De Mulder, G. M. Mead, P. Cook, et al. 2003. “Quality of Life in Good Prognosis Patients with Metastatic Germ Cell Cancer: A Prospective Study of the European Organization for Research and Treatment of Cancer Cancer Study Group (30941/TE20).” Journal of Clinical Oncology 21 (6): 1107–1118. doi:10.1200/JCO.2003.02.075.
  • Fossa, S. D., and S. D. Fossg. 1996. “Patients’ and Doctors’ Perception of Long-Term Morbidity in Patients with Testicular Cancer Clinical Stage I a Descriptive Pilot Study.” Supportive Care in Cancer 4 (2): 118–128. doi:10.1007/BF01845761
  • Frisina, R. D., H. E. Wheeler, S. D. Fossa, S. L. Kerns, C. Fung, H. D. Sesso, P. O. Monahan., et al. 2016. “Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus after Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.” Journal of Clinical Oncology 34 (23): 2712–2720. doi:10.1200/JCO.2016.66.8822.
  • Golder, S., and Y. Loke. 2009. “Search Strategies to Identify Information on Adverse Effects: A Systematic Review.” Journal of the Medical Library Association 97 (2): 84–92. doi:10.3163/1536-5050.97.2.004.
  • Gray, S. A., R. I. Zraick, and S. R. Atcherson. 2019. “Readability of Individuals with Disabilities Education Act Part B Procedural Safeguards: An Update.” Language, Speech, and Hearing Services in Schools 50 (3): 373. doi:10.1044/2018_LSHSS-18-0057.
  • Gurgel, R. K., P. D. Ward, S. Schwartz, M. C. Norton, N. L. Foster, and J. A. T. Tschanz. 2014. “Relationship of Hearing Loss and Dementia: A Prospective, Population-Based Study.” Otology & Neurotology 35 (5): 775–781. doi:10.1097/MAO.0000000000000313.
  • Hogan, A., R. L. Phillips, S. A. Brumby, W. Williams, and C. Mercer-Grant. 2015. “Higher Social Distress and Lower Psycho-Social Wellbeing: Examining the Coping Capacity and Health of People with Hearing Impairment.” Disability and Rehabilitation 37 (22): 2070–2075. doi:10.3109/09638288.2014.996675.
  • Kalyanam, B., N. Sarala, S. M. A. Mohiyuddin, and R. Diwakar. 2018. “Auditory Function and Quality of Life in Patients Receiving Cisplatin Chemotherapy in Head and Neck Cancer: A Case Series Follow-up Study.” Journal of Cancer Research and Therapeutics 14 (5): 1099–1104. doi:10.4103/0973-1482.188426.
  • Kelland, L. 2007. “The Resurgence of Platinum-Based Cancer Chemotherapy.” Nature Reviews Cancer 7 (8): 573–584. doi:10.1038/nrc2167.
  • Loke, Y. K., D. Price, and A. Herxheimer. 2007. “Systematic Reviews of Adverse Effects: Framework for a Structured Approach.” BMC Medical Research Methodology 7 (1): 32. doi:10.1186/1471-2288-7-32.
  • Miaskowski, C., J. Mastick, S. M. Paul, G. Abrams, S. Cheung, J. H. Sabes, K. M. Kober, et al. 2018a. “Impact of Chemotherapy-Induced Neurotoxicities on Adult Cancer Survivors ’ Symptom Burden and Quality of Life.” Journal of Cancer Survivorship 12 (2): 234–245. doi:10.1007/s11764-017-0662-8.
  • Miaskowski, C., S. M. Paul, J. Mastick, G. Abrams, K. Topp, B. Smoot, K. M. Kober, et al. 2018b. “Associations between Perceived Stress and Chemotherapy-Induced Peripheral Neuropathy and Otoxicity in Adult Cancer Survivors.” Journal of Pain and Symptom Management 56 (1): 88. doi:10.1016/j.jpainsymman.2018.02.021.
  • Miaskowski, C., S. M. Paul, J. Mastick, M. Schumacher, Y. P. Conley, B. Smoot, G. Abrams, et al. 2018c. “Hearing Loss and Tinnitus in Survivors with Chemotherapy-Induced Neuropathy.” European Journal of Oncology Nursing 32: 1–11. doi:10.1016/j.ejon.2017.10.006.
  • Mols, F., A. J. J. M. Vingerhoets, J. W. Coebergh, and L. V. van de Poll-Franse. 2005. “Quality of Life among Long-Term Breast Cancer Survivors: A Systematic Review.” European Journal of Cancer 41 (17): 2613–2619. doi:10.1016/j.ejca.2005.05.017.
  • National Heart, Lung, and Blood Institute (NHLBI). 2018. Study Quality Assessment Tools. Accessed November 1. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
  • Nondahl, D. M., K. J. Cruickshanks, D. S. Dalton, B. E. K. Klein, R. Klein, C. R. Schubert, T. S. Tweed, and T. L. Wiley. 2007. “The Impact of Tinnitus on Quality of Life in Older Adults.” Journal of the American Academy of Audiology 18 (3): 257–266. doi:10.3766/jaaa.18.3.7.
  • Nordvik, Ø., P. O. Laugen Heggdal, J. Brännström, F. Vassbotn, A. K. Aarstad, and H. J. Aarstad. 2018. “Generic Quality of Life in Persons with Hearing Loss: A Systematic Literature Review.” BMC Ear, Nose and Throat Disorders 18 (1): 1. doi:10.1186/s12901-018-0051-6.
  • Oldenburg, J., S. D. Fossa, A. A. Dahl, S. D. Fosså, and A. A. Dahl. 2006. “Scale for Chemotherapy-Induced Long-Term Neurotoxicity (SCIN): Psychometrics, Validation, and Findings in a Large Sample of Testicular Cancer Survivors.” Quality of Life Research 15 (5): 791–800. doi:10.1007/s11136-005-5370-6.
  • Oun, R., Y. E. Moussa, and N. J. Wheate. 2018. “The Side Effects of Platinum-Based Chemotherapy Drugs: A Review for Chemists.” Dalton Transactions 47 (19): 6645–6653. doi:10.1039/C8DT00838H.
  • Paken, J., C. D. Govender, M. Pillay, and V. Sewram. 2016. “Cisplatin-Associated Ototoxicity: A Review for the Health Professional.” Journal of Toxicology 2016: 1. doi:10.1155/2016/1809394.
  • Saad, A. S., R. R. Ghali, and M. A. Shawki. 2017. “A Prospective Randomized Controlled Study of Cisplatin versus Carboplatin-Based Regimen in Advanced Squamous Nonsmall Cell Lung Cancer.” Journal of Cancer Research and Therapeutics 13 (2): 198–203. doi:10.4103/0973-1482.187287.
  • Saladin, S. P., R. B. Perez, B. Cruz, Y. Tasnif, and B. Cruz. 2015. “A Review of Ototoxic Medications: Implications for Professionals Working with Consumers with Hearing Loss.” Journal of the American Deafness and Rehabilitation Association 49 (2): 1–8. http://repository.wcsu.edu/jadara
  • Siegel, R. L., K. D. Miller, and A. Jemal. 2018. “Cancer Statistics, 2018.” CA: A Cancer Journal for Clinicians 68 (1): 7–30. doi:10.3322/caac.21442.
  • Skalleberg, J., O. Solheim, S. D. Fosså, M. C. Småstuen, T. Osnes, P. O. M. Gundersen, and M. Bunne. 2017. “Long-Term Ototoxicity in Women after Cisplatin Treatment for Ovarian Germ Cell Cancer.” Gynecologic Oncology 145 (1): 148–153. doi:10.1016/j.ygyno.2017.02.006.
  • Stein, K. D., K. L. Syrjala, and M. A. Andrykowski. 2008. “Physical and Psychological Long-Term and Late Effects of Cancer.” Cancer 112 (S11): 2577–2592. doi:10.1002/cncr.23448.
  • Theile, D. 2017. “Under-Reported Aspects of Platinum Drug Pharmacology.” Molecules 22 (3): 382. doi:10.3390/molecules22030382.
  • Theunissen, E. A. R., W. A. Dreschler, M. N. Latenstein, C. R. N. Rasch, S. Van Der Baan, J. P. De Boer, A. J. M. Balm, and C. L. Zuur. 2014. “A New Grading System for Ototoxicity in Adults.” Annals of Otology, Rhinology & Laryngology 123 (10): 711–718. doi:10.1177/0003489414534010.
  • Travis, L. B., S. D. Fossa, H. D. Sesso, R. D. Frisina, D. N. Herrmann, C. J. Beard, D. R. Feldman., et al. 2014. “Chemotherapy-Induced Peripheral Neurotoxicity and Ototoxicity: New Paradigms for Translational Genomics.” Journal of the National Cancer Institute 106 (5): pii: dju044. doi:10.1093/jnci/dju044.
  • Tserga, E., T. Nandwani, N. K. Edvall, J. Bulla, P. Patel, B. Canlon, C. R. Cederroth, and D. M. Baguley. 2019. “The Genetic Vulnerability to Cisplatin Ototoxicity: A Systematic Review.” Scientific Reports 9 (1): 3455. doi:10.1038/s41598-019-40138-z.
  • Waissbluth, S., E. Peleva, and S. J. Daniel. 2017. “Platinum-Induced Ototoxicity: A Review of Prevailing Ototoxicity Criteria.” European Archives of Oto-Rhino-Laryngology 274 (3): 1187–1196. doi:10.1007/s00405-016-4117-z.
  • Wells, M., C. J. Semple, and C. Lane. 2015. “A National Survey of Healthcare Professionals’ Views on Models of Follow-up, Holistic Needs Assessment and Survivorship Care for Patients with Head and Neck Cancer.” European Journal of Cancer Care 24 (6): 873–883. doi:10.1111/ecc.12285.
  • Wheeler, H. E., L. B. Travis, A. Budnick, D. R. Feldman, L. H. Einhorn, R. J. Hamilton, D. J. Vaughn, et al. 2015. “Comprehensive Characterization of Cisplatin-Related Hearing Loss in U.S. and Canadian Testicular Cancer Survivors (TCS).” Journal of Clinical Oncology 33 (15): 9570–9570. doi:10.1200/jco.2015.33.15_suppl.9570.
  • Zeman, F., M. Koller, B. Langguth, and M. Landgrebe. 2014. “Which Tinnitus-Related Aspects Are Relevant for Quality of Life and Depression: Results from a Large International Multicentre Sample.” Health and Quality of Life Outcomes 12 (1): 7. doi:10.1186/1477-7525-12-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.